NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Corporate Governance Practices Raise Concerns

A recent survey by Excellence Enablers, a leading corporate governance expert, has highlighted concerns regarding the presence of independent directors in Maharatna and Navratna companies.

According to the fifth edition of the survey, a total of 36 Maharatna and Navratna companies failed to meet the mandatory minimum number of independent directors in the fiscal year 2024-25. The survey, which covered 14 Maharatna and 26 Navratna companies, aimed to assess corporate governance practices in these organizations.

The findings of the survey indicate a need for improvement in the area of corporate governance, particularly with regards to the composition of the board of directors.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Investor Takeaway

Investors should monitor corporate governance practices in Indian Public Sector Undertakings for potential long-term implications.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.